The Duramed FUTURES Golf Tour is celebrating its 27th season this year. Growing from a Tour of about 20 players from North America to more than 300 players from 27 different countries and six continents, The Duramed FUTURES Tour has experienced marked growth since its early days in 1981 as the Tampa Bay Mini Tour. Founder Eloise Trainor formed the Tour to offer competitive opportunities for women aspiring to join the LPGA Tour. The goal was, and still is, to help players develop their golf skills and graduate to the LPGA Tour. Renamed the FUTURES Golf Tour in 1984, the organization quickly grew from an in-state Florida Tour to a Tour with players from Argentine to Zimbabwe. In 2005, the Tour entered into a 3-year Title sponsorship agreement with Duramed Pharmaceuticals, changing the name to the Duramed FUTURES Tour beginning in 2006. The Duramed FUTURES Tour is now the largest international developmental tour and the second largest women's golf tour in the world, featuring an 18-tournament schedule in 13 states and a total purse of over $1.35 million.

While the Tour's membership, tournament schedule and charitable fundraising has grown in the last quarter century, the objective has remained the same since its earliest days: to provide the opportunity for women professional golfers to develop their skills and move on to the LPGA Tour, to allow tournament host communities to meet and embrace future LPGA stars, and to allow business communities and corporate leaders at host tournament sites to link with local charities, using a professional golf tournament setting to raise funds for local projects.

Since 1989, Duramed FUTURES Tour events have raised nearly $4 million for a range of community-based charitable organizations, such as Chip In For A Cure, the First Tee of Lakeland, the Albany (N.Y.) Police & Fire Foundation and the Betty Puskar Breast Care Center. Tournaments are staged in a cross-section of American cities with widespread community participation and support of local charities.